Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Allergy Clin Immunol ; 105(3): 482-8, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10719297

ABSTRACT

BACKGROUND: Mite allergen vaccines are important diagnostic and immunotherapeutic reagents. Previous studies on mite allergen stability under different storage conditions have yielded contradictory results. OBJECTIVE: We sought to compare, over a 12-month period, the stability of mite allergens reconstituted in 50% glycerol and stored at different temperatures and to examine the role of protease inhibitors in enhancing allergen stability. METHODS: Lyophilized allergen extracts were reconstituted in 50% glycerol, with and without protease inhibitors, and stored at -70 degrees C, -20 degrees C, 4 degrees C, or 37 degrees C for 12 months. At 6 and 12 months, the extracts were compared with freshly dissolved extracts by competition ELISA with pooled allergic sera, 2-site ELISA with mite-specific mAbs, and immunoblot analyses. RESULTS: The overall potencies of the stored extracts measured by competition ELISA were stable at -20 degrees C and 4 degrees C. As determined by means of the immunoblot and 2-site ELISA, Der f 1 levels decreased at 4 degrees C. Levels of Der f 2, Der p 1, and Der p 2 decreased in at least one of the allergen-specific assays. Storage at 37 degrees C led to overall loss of potency and allergen content, whereas storage at -70 degrees C was associated with a moderate loss of potency that increased with multiple freeze-thaw cycles. Protease inhibitors had no effect on allergen stability. CONCLUSION: Although overall potency of the extracts, as measured by competition ELISA, was preserved at -20 degrees C and 4 degrees C, allergen-specific assays indicated loss of allergens. These findings suggest that the competition ELISA is insensitive to decreases in the concentrations of individual allergens.


Subject(s)
Glycerol/metabolism , Glycoproteins/chemistry , Tissue Extracts/immunology , Animals , Antibodies, Monoclonal/immunology , Antibody Specificity , Antigens, Dermatophagoides , Drug Stability , Enzyme-Linked Immunosorbent Assay/methods , Glycoproteins/drug effects , Glycoproteins/standards , Immunoblotting , Mites/immunology , Protease Inhibitors/pharmacology , Tissue Extracts/standards
2.
Mol Immunol ; 36(2): 135-43, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10378685

ABSTRACT

Hev b 5, a proline-rich acidic protein with a predominantly random secondary structure, is a major allergen in natural rubber latex and a candidate for specific immunotherapy of latex allergy. As a first step in the identification of candidate peptides for immunotherapy, we have begun to identify the B-cell and T-cell epitopes of Hev b 5 in BALB/c mice. The mice were immunized with a Hev b 5 fusion protein. The B-cell epitopes were determined by the SPOTS method using overlapping octamers or by ELISA inhibition using a series of overlapping 20-mers. The T-cell epitopes were determined by the proliferation and cytokine release of splenocytes cultured in the presence of the 20-mers. Potential antibody binding regions included residues in regions 1-38, 55-74, 109-128 and 132-151. Examination of the binding sequences for common motifs suggested enhanced antibody binding to the KXEE or KEXE sequences, where X is empty, threonine or alanine. Splenocyte stimulation and cytokine release suggest T-cell epitopes with the regions 1-20, 37-56, 73-101 and 109-146. Since they may contain major T-cell epitopes but do not exhibit significant antibody binding, peptide regions 38-48 and 75-101 are candidates for specific immunotherapy to Hev b 5 in the BALB/c mouse model.


Subject(s)
Allergens/immunology , B-Lymphocytes/immunology , Epitopes/immunology , Latex Hypersensitivity/immunology , T-Lymphocytes/immunology , Allergens/genetics , Amino Acid Sequence , Animals , Antigen Presentation , Antigens, Plant , Epitopes/genetics , Lymphocyte Cooperation , Mice , Molecular Sequence Data , Peptide Fragments/genetics , Peptide Fragments/immunology , Plant Proteins , Sequence Analysis
3.
J Surg Res ; 82(2): 324-30, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10090847

ABSTRACT

BACKGROUND: Gastrointestinal function is controlled partly by an interaction between extrinsic (sympathetic, parasympathetic, sensory) and intrinsic (enteric) nerves. However, normal gut function occurs in the absence of extrinsic innervation as enteric nerves adapt to the loss of extrinsic nerves from the gut wall. Expression of the proto-oncogene product, c-Fos, is a signal for activity-dependent changes in gene expression and immunocytochemical detection of c-Fos is used as a marker for changes in neuronal activity. The purpose of this study was to determine if enteric neurons in guinea pig ileum respond to loss of extrinsic innervation by expressing c-Fos protein. MATERIALS AND METHODS: Fos protein was localized using immunohistochemical methods and an antiserum raised against synthetic Fos. Segments of ileum were extrinsically denervated by crushing the mesenteric nerves in anesthetized animals or by treating animals with 6-hydroxydopamine (6-OH-DA) or capsaicin to destroy sympathetic and extrinsic sensory nerves, respectively. RESULTS: One week after surgical extrinsic denervation of loops of ileum, 12 +/- 1 nuclei/submucosal ganglion and 114 +/- 6 nuclei/myenteric ganglion contained Fos immunoreactivity (ir). These values were greater (P < 0.05) than those from unoperated segments from the same animals (4 +/- 1 Fos-ir nuclei/submucosal ganglion and 13 +/- 4 Fos-ir nuclei/myenteric ganglion) or from sham-operated segments. Significantly more nuclei contained Fos-ir at 4, 7, 10, and 24 weeks after denervation. Finally, capsaicin or 6-OH-DA treatment increased the number of Fos-ir nuclei in enteric ganglia. CONCLUSIONS: These data suggest that Fos expression may be part of the adaptation of enteric nerves to extrinsic denervation.


Subject(s)
Denervation , Enteric Nervous System/metabolism , Ileum/innervation , Proto-Oncogene Proteins c-fos/metabolism , Animals , Ganglia/metabolism , Guinea Pigs , Male , Myenteric Plexus/metabolism , Neurons, Afferent/physiology , Reference Values , Submucous Plexus/metabolism , Sympathetic Nervous System/physiology
4.
J Allergy Clin Immunol ; 102(6 Pt 1): 977-83, 1998 Dec.
Article in English | MEDLINE | ID: mdl-9847439

ABSTRACT

BACKGROUND: LPS is a common contaminant in the health care environment and in latex examination gloves. OBJECTIVE: We sought to investigate the role of LPS in enhancing the immune responses of mice to inhaled latex allergen. METHODS: As our model allergen, we used a fusion protein containing the potent latex allergen Hev b 5. BALB/c mice were lightly anesthetized and given repeated intranasal doses of saline, LPS, and/or Hev b 5. The doses were given in 2 courses separated by a 6-week period, with the first course consisting of 6 doses and the second consisting of 3 doses. RESULTS: After the first set of immunizations, mice given Hev b 5 alone had no detectable IgG1 or IgE responses to Hev b 5, whereas mice given the antigen along with LPS had significant responses (IgG1, 0.73 U +/- 0.05; IgE, 0.88 U +/- 0.2). No enhancement of specific IgG2a was observed. A stimulatory effect of LPS on all 3 immunoglobulin types was apparent after the second course. Lymphocytes from mice immunized with LPS and Hev b 5 had increased proliferation to Hev b 5 and its fusion partner. CONCLUSIONS: LPS may be an important immunoadjuvant for the development of allergic reactions to latex protein allergens.


Subject(s)
Adjuvants, Immunologic/administration & dosage , Allergens/immunology , Immunoglobulin E/biosynthesis , Immunoglobulin G/biosynthesis , Latex/immunology , Lipopolysaccharides/administration & dosage , Administration, Intranasal , Allergens/administration & dosage , Animals , Antigens, Plant , Cells, Cultured , Female , Immunoglobulin E/blood , Immunoglobulin G/blood , Lymphocyte Activation , Mice , Mice, Inbred BALB C , Plant Proteins
SELECTION OF CITATIONS
SEARCH DETAIL
...